Vivos Therapeutics
Stock Forecast, Prediction & Price Target
Vivos Therapeutics Financial Estimates
Vivos Therapeutics Revenue Estimates
Vivos Therapeutics EBITDA Estimates
Vivos Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $16.88M N/A | $16.02M -5.09% | $13.80M -13.87% | Avg: $18.40M Low: $18.40M High: $18.40M avg. 33.37% | |||
Net Income
% change YoY
| $-20.29M N/A | $-22.65M -11.65% | $-13.58M 40.05% | Avg: $-10.53M Low: $-3.68M High: $-1.82M avg. 22.44% | |||
EBITDA
% change YoY
| $-18.63M N/A | $-24.46M -31.30% | $-16.67M 31.83% | Avg: $-17.38M Low: $-17.38M High: $-17.38M avg. -4.22% | |||
EPS
% change YoY
| -$23.89 N/A | -$24.62 -3.05% | -$11.14 54.75% | Avg: -$2.26 Low: -$3.02 High: -$1.5 avg. 79.71% | |||
Operating Expenses
% change YoY
| $32.07M N/A | $35.05M 9.27% | $24.94M -28.82% | Avg: $32.51M Low: $32.51M High: $32.51M avg. 30.35% | |||
FAQ
What is Vivos Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 22.44% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is -3.68M, average is -10.53M and high is -1.82M.
What is Vivos Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 33.37% in 2025-2025.
We have gathered data from 1 analysts. Their low revenue estimate is $18.40M, average is $18.40M and high is $18.40M.
What is Vivos Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 79.71% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$3.02, average is -$2.26 and high is $-1.5.